Having demonstrated that HBV-SRL upregulated the NF-κB2 expression and was involved in cell migration in vitro, we evaluated the relationship between the HBV-SRL and NF-κB2 expression and recurrence in HCC patients with different level of HBV DNA. The gene discussed is NFKB2; the disease is hepatocellular carcinoma.